Current problems of the clinical use and laboratory control of heparin treatment. 1985

G Sas

UI MeSH Term Description Entries
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses

Related Publications

G Sas
October 1989, Seminars in thrombosis and hemostasis,
G Sas
January 1980, Scandinavian journal of haematology. Supplementum,
G Sas
January 1977, Federation proceedings,
G Sas
January 2006, Analytical and bioanalytical chemistry,
G Sas
January 1989, La Ricerca in clinica e in laboratorio,
G Sas
May 1971, The Medical journal of Australia,
G Sas
July 1975, Current therapeutic research, clinical and experimental,
Copied contents to your clipboard!